MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria
about
Identification of postoperative prognostic microRNA predictors in hepatocellular carcinomaDysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasisMicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinomaRole of epigenetic aberrations in the development and progression of human hepatocellular carcinomaThe antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model.Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation.FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells.High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer.Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues.A meta-analysis of microRNA expression in liver cancer.Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-METMicroRNA Profiling of Laser-Microdissected Hepatocellular Carcinoma Reveals an Oncogenic Phenotype of the Tumor CapsuleMicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas.Circulating tumor cells measurements in hepatocellular carcinoma.Computational identifying and characterizing circular RNAs and their associated genes in hepatocellular carcinoma.Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma.Identification of recurrence-related serum microRNAs in hepatocellular carcinoma following hepatectomy.SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497LIN28 expression and prognostic value in hepatocellular carcinoma patients who meet the Milan criteria and undergo hepatectomy.The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.Let-7a enhances the sensitivity of hepatocellular carcinoma cells to cetuximab by regulating STAT3 expression.Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues.An Explorative Analysis for the Role of Serum miR-10b-3p Levels in Predicting Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma.The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 geneSurgical treatment for large hepatocellular carcinoma: does size matter?Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge.MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?The role and clinical implications of microRNAs in hepatocellular carcinoma.Update on biomarkers of hepatocellular carcinoma.Specific molecular signatures of non-tumor liver tissue may predict a risk of hepatocarcinogenesis.The ins and outs of microRNAs as biomarkers in liver disease and transplantation.Non-Coding RNAs in Primary Liver Cancer.miRNA for diagnosis and clinical implications of human hepatocellular carcinoma.
P2860
Q21134574-586B1415-C46C-4748-97A9-BA461CAFAA4DQ26747871-1D5ECDCC-CD82-41DD-ABED-68A0ABA1EC0AQ26751392-9A792305-267E-454D-B7F5-709485DBB986Q27023524-C5535D6D-0EBD-4159-83B7-7389A04DD627Q28535282-5CCE2871-D761-45BE-BDA5-041778712738Q31037974-B1F5D82D-1577-480A-946B-CF8325F44F54Q31164960-2DFEB808-BBC8-4F13-82CF-8E0234B35B4BQ33660974-8651C9A7-0F88-43FE-BE1D-705198348AB3Q34050935-F39FCBE6-0341-40BE-B47E-3903BF11F962Q34104157-A93173B9-B9E5-43A6-9AEB-B1449D3B1491Q34181700-AA960EA3-0D81-4474-BC15-EBDD4CA56008Q34479270-FA4455E8-2599-4C0E-826F-BAF03CF9497DQ34548464-5DB3A5C9-1AFD-44AA-9CFA-1B30126CBECDQ34645417-DB3B320A-A3A7-4D21-8D94-1EA4A74B66FAQ34662934-02848F4E-270B-4A2C-BC2A-78262EB86DECQ34674537-EDB4DFDF-B297-4503-964A-F1C8446B9440Q35028814-B44577AF-A753-4007-9F3B-A579F188B6C9Q35113043-448B9C47-302C-4E64-9B77-87E7D987CE97Q35752063-73E691EE-53E0-47D1-A797-4BE01062DAF0Q36011412-B7371F94-9879-402B-9CB3-F4839434E588Q36323741-B6126565-FFAF-43D8-9067-1FB0E69D2A35Q36413124-12B627EB-D38D-4BB7-B1D0-95F8A84A3CFAQ36772208-6B59A1C2-4422-4D65-9C4B-A87FAFFE0090Q36839031-AB0F275B-E7CB-48F3-97E2-13C19BD82CDBQ36939787-16D87CA6-65FD-4BC2-8A70-EF7A1DDE1712Q37183805-C7CDB55D-004B-4A28-BDAB-7D85CBF6172DQ37363464-BABA0A0C-BD97-4299-9163-2E36EEF2E416Q37469797-7195ABC4-4E4E-4B11-92BE-605895DB3CC0Q37564156-D364774B-A3CD-4B91-9FF0-C4B8BDEF8E16Q37570142-5CA09619-44CB-4B83-9BCD-DD132E261661Q37605126-63B73292-8B37-400B-8055-7DCB06D12504Q38006772-00CB8AFB-109F-4BBE-B4B2-E5E61DE70013Q38045000-1331DD4C-C5C6-4616-BCCB-F35904735FBFQ38053397-48CFDAF6-B71F-4BDA-926F-3D31ED19E6E9Q38056415-87845710-E7C4-4F79-9D8B-6C64138239F1Q38166133-4467A6DE-55CF-4F2F-898C-F05518F11AD0Q38207102-88442FEB-13F9-4C14-8E21-A69A47606CACQ38223103-7BD5285A-9D33-4B53-B37F-3BA1049F99EBQ38541359-A583F26E-B660-4A62-9CCD-B90F1674E83FQ38568853-95EA215E-E60E-4FB4-AC78-EA0D87868E47
P2860
MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MicroRNA profile predicts recu ...... noma within the Milan Criteria
@ast
MicroRNA profile predicts recu ...... noma within the Milan Criteria
@en
MicroRNA profile predicts recu ...... noma within the Milan Criteria
@nl
type
label
MicroRNA profile predicts recu ...... noma within the Milan Criteria
@ast
MicroRNA profile predicts recu ...... noma within the Milan Criteria
@en
MicroRNA profile predicts recu ...... noma within the Milan Criteria
@nl
prefLabel
MicroRNA profile predicts recu ...... noma within the Milan Criteria
@ast
MicroRNA profile predicts recu ...... noma within the Milan Criteria
@en
MicroRNA profile predicts recu ...... noma within the Milan Criteria
@nl
P2093
P2860
P3181
P1433
P1476
MicroRNA profile predicts recu ...... noma within the Milan Criteria
@en
P2093
Akira Myomoto
Etsuro Hatano
Fumiaki Sato
Gozoh Tsujimoto
Kazuharu Shimizu
Koji Kitamura
Satoko Takizawa
Shinji Uemoto
Soken Tsuchiya
Takeshi Fujiwara
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0016435
P407
P577
2011-01-27T00:00:00Z